Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI. The Irish Association for Cancer Research (IACR), Signal Transduction Society (STS) and Spanish Association for Cancer Research (ASEICA) are affiliated with Cancers and their members receive a discount on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.
  • Journal Rank: JCR - Q1 (Oncology) / CiteScore - Q2 (Oncology)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 18.5 days after submission; acceptance to publication is undertaken in 3.3 days (median values for papers published in this journal in the second half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
  • Sections: published in 15 topical sections.
  • Companion journals for Cancers include: Radiation and Onco.
Impact Factor: 6.639 (2020) ; 5-Year Impact Factor: 6.999 (2020)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomolecules, Cancers, Cells, Current Oncology
Advances in Ovarian Cancer Research: From Biology to Therapeutics Topic Editors: Christina M. Annunziata, Adam R. Karpf
Deadline: 31 May 2022
Topic in Biomolecules, Cancers, Current Oncology, IJMS, Onco
Novel Approaches in Bladder Cancer Treatment Topic Editors: Roman Blaheta, Beatrice E. Bachmeier
Deadline: 31 July 2022
Topic in Cancers, Diagnostics, Hemato, JCM, Tomography
MRI and PET/MRI in Hematology and Oncology Topic Editors: Francesca Maccioni, Leonardo Pace
Deadline: 30 September 2022
Topic in Antibodies, Cancers, Immuno, IJMS, Vaccines
Anti-Tumor Immune Responses Topic Editors: Massimo Zollo, Erle S. Robertson, Renata Grifantini
Deadline: 14 October 2022
Special Issue in Cancers
Management of Early Stage Cervical Cancer Guest Editors: Valerio Gallotta, Luigi Pedone Anchora
Deadline: 15 June 2022
Special Issue in Cancers
Therapies in Cervical Cancer Guest Editors: Raj Naik, Nick Wood, Antonios Anagnostopoulos, Dennis Yiannakis
Deadline: 20 June 2022
Special Issue in Cancers
Diagnostic and Predictive Tissue Markers in GI Cancers Guest Editor: Francesco Vasuri
Deadline: 15 July 2022
Topical Collection in Cancers
Drug Resistance and Novel Therapies in Cancers Collection Editor: Zhixiang Wang
Topical Collection in Cancers
The Role of Non-coding RNA in Cancer Collection Editor: Lyndsay Rhodes
Topical Collection in Cancers
Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer 2.0 Collection Editors: Éléna Paillaud, Pierre Soubeyran, Marije Hamaker
Topical Collection in Cancers
Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications Collection Editors: Patrizia Limonta, Fabrizio Fontana
Back to TopTop